Clinical trial · Observational
Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients
Characterization of Biophysical and Mechanical Parameters on the Skin of Subjects With a Diagnosis of Breast Cancer After Surgery and Undergoing Adjuvant Treatment.
NCT06474988CI-TRIAL-00078261unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Aim of this study is to characterize the chemical/physical and structural parameters of the skin in patients with breast cancer undergoing oncological adjuvant treatment in order to understand how to prevent and manage adverse skin events during hormone therapy, also through the formulation of new functional dermocosmetics.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Estrogen Receptor Positive Tumor | Breast Neoplasm | PROBABILISTIC | 0.70 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Skin tests | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Tamoxifen
- description
- Patients who are receiving treatment with tamoxifen in adjuvant setting
- interventionNames
- Other: Skin tests
- label
- Aromatase Inhibitors
- description
- Patients who are receiving treatment with an aromatase inhibitor in adjuvant setting
- interventionNames
- Other: Skin tests
- label
- Paclitaxel
- description
- Patients who are receiving treatment with Paclitaxel in adjuvant setting
- interventionNames
- Other: Skin tests
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * age between 40 and 70 years * subjects who are receiving treatment with tamoxifen, aromatase inhibitor or paclitaxel in adjuvant therapy +/- adjuvant radiotherapy * subjects who are receiving hormonal therapy must have suspended any chemotherapy for at least 30 days Exclusion Criteria: * presence of known chronic skin pathologies before adjuvant treatment start (psoriasis, lupus, atopic dermatitis) * inability to understand and will * unavailability to carry out all the tests required by the protocol
References
Publications (0)
Data not yet available
No reference posted for this study.